All Stories

  1. cost-effectiveness of bortezomib

    Article • ClinicoEconomics and Outcomes Research, May 2016, Dove Medical Press

    Dr Yicheng Yang, Du Fen

  2. Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis

    Article • ClinicoEconomics and Outcomes Research, April 2015, Taylor & Francis

    Mr Jay Zhang, Dr Yicheng Yang, Du Fen

  3. Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study

    Article • Drugs - Real World Outcomes, February 2015, Springer Science + Business Media

    Dr Yicheng Yang

  4. Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study

    Article • BMC Cancer, December 2014, Springer Science + Business Media

    Dr Yicheng Yang

  5. Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study

    Article • ClinicoEconomics and Outcomes Research, October 2014, Taylor & Francis

    Dr Yicheng Yang

  6. Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study

    Article • Thoracic Cancer, August 2014, Wiley

    Dr Yicheng Yang

  7. Prognostic factors for patients with advanced non-small cell lung cancer treated with gemcitabine-platinum as first-line therapy in an observational setting in China

    Article • Thoracic Cancer, July 2014, Wiley

    Dr Yicheng Yang